| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10983757 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 164 journal articles in the PubMed database | Email to a friend | | |
| Menda Y, Bushnell DL, Williams RD, et al.
Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain. [Case Reports, Clinical Trial, Clinical Trial, Phase III, Journal Article]
Clin Nucl Med 2000 Sep; 25(9):698-700.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Sartor O, Reid RH, Bushnell DL, et al.
Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain. [JOURNAL ARTICLE]
Cancer 2006 Dec 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dolezal J, Vizda J, Odrazka K
Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-Refractory Prostate Cancer. [Journal Article]
Urol Int 2007; 78(1):50-7.
Abstract | Full Citation | Find Related Articles | | Ripamonti C, Fagnoni E, Campa T, et al.
Incident pain and analgesic consumption decrease after samarium infusion: a pilot study. [JOURNAL ARTICLE]
Support Care Cancer 2006 Sep 12.
Abstract | Full Citation | | Sartor O, Reid RH, Hoskin PJ, et al.
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial]
Urology 2004 May; 63(5):940-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Serafini AN, Houston SJ, Resche I, et al.
Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 1998 Apr; 16(4):1574-81.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Liepe K, Runge R, Kotzerke J
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. [Clinical Trial, Controlled Clinical Trial, Journal Article]
J Cancer Res Clin Oncol 2005 Jan; 131(1):60-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Resche I, Chatal JF, Pecking A, et al.
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Eur J Cancer 1997 Sep; 33(10):1583-91.
Abstract | Full Citation | Find Related Articles | | Dolezal J, Vizd'a J, Cermáková E
[Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ] [Journal Article]
Vnitr Lek 2003 Mar; 49(3):189-93.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
